JAZZ vs STEM · P/E 1988, rev $4.07B vs rev $144.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. STEM currently screens at market cap $82.1M.
Not investment advice. Open the JAZZ and STEM stock pages for the full models.
Not investment advice.